Adial Pharmaceuticals, Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
8.50
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.17
|
0.00
|
0.17
|
100.00%
|
|
2022-09-30
|
-0.18
|
-0.12
|
0.06
|
33.33%
|
|
2022-06-30
|
-0.14
|
-0.16
|
-0.02
|
-14.29%
|
|
2022-03-31
|
-0.17
|
-0.13
|
0.04
|
23.53%
|
|
2021-12-31
|
-0.21
|
-0.28
|
-0.07
|
-33.33%
|
|
2021-09-30
|
-0.22
|
-0.22
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.20
|
-0.25
|
-0.05
|
-25.00%
|
|
2021-03-31
|
-0.15
|
-0.30
|
-0.15
|
-100.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.41
|
|
2021-12-31
|
-1.05
|
|
2020-12-31
|
-0.86
|
|
2019-12-31
|
-0.84
|
|
2018-12-31
|
-1.29
|